EARLY EVALUATION OF HISTOLOGICAL MARKERS OF FIBROSIS AND CELLULAR PROLIFERATION IN LIVER TRANSPLANT PATIENTS WITH HCV RECURRENCE

被引：0
|
作者：
Mensa, L. [1 ]
Marino, Z. [1 ]
Crespo, G. [1 ]
Lens, S. [1 ]
Miquel, R. [2 ]
Carrion, J. [1 ]
Perez-del-Pulgar, S. [1 ]
Forns, X. [1 ]
Navasa, M. [1 ]
机构：
[1] Hosp Clin Barcelona, CIBERehd, IDIBAPS, Liver Unit, Barcelona, Spain
[2] Hosp Clin Barcelona, CIBERehd, IDIBAPS, Dept Pathol, Barcelona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60171-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
169
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [31] LIVER HISTOLOGY ONE YEAR POST-TRANSPLANT PREDICTS PROGRESSION OF FIBROSIS AND DEFINES SEVERE HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION
    Ydreborg, Magdalena
    Dhillon, Amar P.
    Burroughs, A. K.
    Lagging, Martin
    Manousou, Pinelopi
    Westin, Johan
    HEPATOLOGY, 2009, 50 (04) : 546A - 546A
  • [32] CELLULAR PROLIFERATION MARKERS IN THE EVALUATION OF HUMAN CANCER
    RILEY, RS
    CLINICS IN LABORATORY MEDICINE, 1992, 12 (02) : 163 - 199
  • [33] Cellular apoptosis and proliferation in experimental liver fibrosis.
    Tsamandas, A
    Felekouras, E
    Salakou, S
    Kourelis, T
    Bastounis, E
    Bonikos, D
    Papalampros, E
    Michalopoulos, G
    LABORATORY INVESTIGATION, 2001, 81 (01) : 204A - 204A
  • [34] Progression of Fibrosis in Maintenance Liver Transplant Recipients with HCV Recurrence Converted to Everolimus: Results of a Multicenter, Randomized, Controlled Study
    Villamil, F.
    Gadano, A.
    Zingale, F.
    Perez, R.
    Gil, O.
    Yantorno, S.
    Mastai, R.
    Otero, A.
    Wang, Y.
    Lopez, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 84 - 84
  • [35] Treatment of HCV Recurrence After Liver Transplant: A Review of Early Virologic Responses Using Telaprevir, A Single Center Experience of 24 Patients
    Cece, Elizabeth
    Neff, Guy W.
    Parkinson, Erin S.
    Kemmer, Nyingi
    Evans, Brenna J.
    Blake, Michelle
    Barber, Kristina
    Potter, Teresa
    Silverman, Andrew
    Christian, Macnish B.
    Doligalski, Christina
    Logan, Angela
    Nelson, Annelise
    Alsina, Angel E.
    GASTROENTEROLOGY, 2013, 144 (05) : S955 - S955
  • [36] The Combination of Simeprevir and Sofosbuvir for the Treatment of HCV Infection in Patients Post Liver Transplant With Significant Fibrosis
    Suliman, Idrees
    Pozza, Renee
    Kady, Yaseen
    Hill, Catherine
    Couturier, Thomas A.
    Reshamwala, Preeti
    Hassanein, Tarek
    HEPATOLOGY, 2014, 60 : 545A - 545A
  • [37] Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?
    Sanvisens, Arantza
    Munoz, Alvaro
    Bolao, Ferran
    Zuluaga, Paola
    Farre, Magi
    Jarrin, Inmaculada
    Tor, Jordi
    Muga, Roberto
    DRUG AND ALCOHOL DEPENDENCE, 2018, 188 : 180 - 186
  • [38] Evaluation of serum markers of liver fibrosis in chronic hepatitis C patients
    Sampson, E. L.
    Parkes, J.
    Ryder, S.
    Harris, S.
    Petry, C.
    Anderson-Mauser, L.
    Vajdi, M.
    Rosenberg, W.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A47 - A48
  • [39] Sinusoidal Dilatation after Liver Transplant. A Predictor of HCV Recurrence?
    Theodoropoulos, Ioannis
    Nagai, Shunji
    Schnickel, Gabriel
    David, Bruno
    Kazimi, Marwan
    Yoshida, Atsushi
    Abouljoud, Marwan
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 101 - 101
  • [40] Histological and clinical outcome of HCV liver transplanted patients
    Morelli, MC
    Polifemo, AM
    DeVergori, E
    Mimmo, RA
    Marchetto, S
    Sottili, S
    Mazzeo, C
    Casanova, S
    Roda, E
    GASTROENTEROLOGY, 1997, 112 (04) : A1337 - A1337
12345